神经诊断市场规模、份额和成长分析（按产品、疾病状况、最终用户和地区）- 产业预测 2025-2032

2023 年神经诊断市场规模价值 99 亿美元，预计将从 2024 年的 107.9 亿美元成长到 2032 年的 215 亿美元，预测期间（2025-2032 年）的复合年增长率为 9.0%。

由于神经系统疾病发病率上升、人口老化和技术进步，神经诊断市场正在经历显着增长。早期和准确疾病检测的技术创新，特别是神经退化性疾病的检测，正在透过蛋白质组学和基因组学的整合来提高诊断的准确性。全球医院和诊断中心数量的不断增加，提高了人们获取先进诊断技术的管道，进一步推动了市场扩张。神经诊断中对生物学分析的需求也日益增加。但挑战依然存在，包括严格的法规和发展中地区有限的需求。儘管如此，神经诊断药物在临床研究中的应用快速增长以及新兴经济体中尚未开发的潜力表明其前景光明。预计未来几年美国神经诊断市场将保持显着成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

神经诊断市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 诊断和影像系统
  • 脑电图 (EEG) 系统
  • 肌电图 (EMG) 产品
  • 磁振造影(MRI) 系统
  • 超音波影像系统
  • 电脑断层扫描 (CT) 扫描仪
  • 脑磁图 (MEG) 系统
  • 正子断层扫描（PET）系统
  • 血管造影术系统
  • 其他系统
• 临床检测设备
  • PCR
  • 次世代定序（NGS）
  • 桑格定序
  • 其他临床诊断产品
• 试剂和耗材
  • 培养基和血清
  • 溶剂
  • 酵素 蛋白质 多胜肽
  • 探测
  • 缓衝
  • 抗体
  • 其他试剂

神经诊断药物市场规模（按病理学和复合年增长率） (2025-2032)

• 市场概况
• 神经退化性疾病
• 癫痫
• 中风
• 头痛症
• 睡眠障碍
• 其他条件

神经诊断市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概况
• 医院和外科中心
• 神经内科中心
• 门诊治疗中心
• 诊断实验室和影像中心
• 研究办公室和学术机构

神经诊断市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（US）
• GE Healthcare（US）
• Koninklijke Philips（Netherlands）
• FUJIFILM（Japan）
• Lifelines Neuro（US）
• Advanced Brain Monitoring（US）
• Nihon Kohden（Japan）
• Hoffmann-La Roche（Switzerland）
• Canon Medical Systems（Japan）
• Danaher（US）
• Abbott Laboratories（US）
• Becton, Dickinson and Company（BD）（US）
• Johnson & Johnson（US）
• Medtronic（Ireland）
• Stryker（US）
• Intuitive Surgical（US）
• Zimmer Biomet（US）
• Smith & Nephew（UK）

结论和建议

Neurodiagnostics Market size was valued at USD 9.9 billion in 2023 and is poised to grow from USD 10.79 billion in 2024 to USD 21.5 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The neurodiagnostic market is witnessing significant growth driven by rising rates of neurological disorders, an aging population, and advancements in technology. Innovations in early and accurate disease detection, particularly for neurodegenerative conditions, are enhancing diagnostic precision through the integration of proteomics and genomics. The increasing number of hospitals and diagnostic centers worldwide is further promoting market expansion as access to advanced diagnostic technology improves. Demand for biological profiling in neurological diagnoses is also increasing. However, challenges remain, including stringent regulations and limited demand in developing regions. Nevertheless, the burgeoning application of neurodiagnostics in clinical studies and the untapped potential in emerging economies indicate a promising future. The US neurodiagnostics market is projected to sustain substantial growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurodiagnostics Market Segments Analysis

Global Neurodiagnostics Market is segmented by Product, Condition, End-User and region. Based on Product, the market is segmented into Diagnostic and Imaging Systems, Clinical Testing Instruments and Reagents & Consumables. Based on Condition, the market is segmented into Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Diseases. Based on End-User, the market is segmented into Hospitals and Surgery Centers, Neurology Centers, Ambulatory Care Centers, Diagnostic Laboratories & Imaging Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurodiagnostics Market

The neurodiagnostics market is experiencing significant growth primarily due to the rising prevalence of neurological disorders, including epilepsy, Parkinson's disease, and Alzheimer's disease. As the number of individuals affected by these conditions continues to rise, there is an increasing demand for advanced diagnostic technologies within healthcare settings. This trend has led to a greater adoption of neurodiagnostic tools and instruments, as healthcare providers seek sophisticated solutions to accurately identify and monitor these disorders. Consequently, the market is expanding as stakeholders respond to the urgent need for effective diagnostic methodologies in the face of escalating neurological health challenges.

Restraints in the Neurodiagnostics Market

A significant obstacle in the neurodiagnostics market is the stringent regulations governing the approval and marketing of neurodiagnostic devices. These lengthy procedures and intricate guidelines can hinder innovation and postpone the launch of new technologies. Such delays adversely affect the overall expansion of the neurodiagnostics sector, especially in regions with rigorous healthcare regulations. As a result, the potential for technological advancements is stifled, making it challenging for companies to introduce innovative solutions promptly, ultimately limiting the market's growth and accessibility of neurodiagnostic services for patients who could benefit from them.

Market Trends of the Neurodiagnostics Market

The neurodiagnostics market is increasingly influenced by the advancements in genomics and personalized medicine, which are revolutionizing the approach to diagnosing and treating neurological disorders. As healthcare providers leverage genetic profiling and proteomic data, they can tailor treatments to individual patients, significantly improving therapeutic outcomes. This trend is driving demand for advanced diagnostic tools that enable precise identification of underlying genetic factors contributing to neurological conditions. Consequently, the market is witnessing a shift towards sophisticated techniques such as next-generation sequencing and high-throughput screening, enhancing the overall efficacy and personalization of patient care within the neurodiagnostic landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Neurodiagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Diagnostic and Imaging Systems
  • Electroencephalogram (EEG) Systems
  • Electromyography (EMG) Products
  • Magnetic Resonance Imaging (MRI) Systems
  • Ultrasound Imaging Systems
  • Computed Tomography (CT) Scanner
  • Magnetoencephalogram (MEG) System
  • Position emission tomography (PET) System
  • Angiography System
  • Other Systems
• Clinical Testing Instruments
  • PCR
  • Next-Generation Sequencing (NGS)
  • Sanger Sequencing
  • Other Clinical Diagnostic Products
• Reagents & Consumables
  • Media and Serra
  • Solvents
  • Enzymes, Protein & Peptides
  • Probes
  • Buffers
  • Antibodies
  • Other Reagents

Global Neurodiagnostics Market Size by Condition & CAGR (2025-2032)

• Market Overview
• Neuro Degenerative Diseases
• Epilepsy
• Stroke
• Headache Disorders
• Sleep Disorders
• Other Diseases

Global Neurodiagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals and Surgery Centers
• Neurology Centers
• Ambulatory Care Centers
• Diagnostic Laboratories & Imaging Centers
• Research Laboratories & Academic Institutes

Global Neurodiagnostics Market Size & CAGR (2025-2032)

• North America (Product, Condition, End-User)
  • US
  • Canada
• Europe (Product, Condition, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Condition, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Condition, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Condition, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifelines Neuro (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Brain Monitoring (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intuitive Surgical (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations